| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/30/2007 | US20070202039 Solid-Phase Preparation of [18F]Fluorohaloalkanes |
| 08/30/2007 | CA2643603A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 08/30/2007 | CA2643561A1 Cancerous disease modifying antibody 141205-05 |
| 08/30/2007 | CA2643144A1 Cancerous disease modifying antibody 141205-04 |
| 08/30/2007 | CA2643063A1 Cancerous disease modifying antibody 141205-02 |
| 08/29/2007 | EP1824830A1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality |
| 08/29/2007 | EP1824525A1 STABILISED 99mTC COMPOSITIONS |
| 08/29/2007 | EP1824524A1 Magnetic resonance contrast media |
| 08/29/2007 | EP1824520A2 Methods of detecting prostate cancer |
| 08/29/2007 | EP1824473A1 Radioactive chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method |
| 08/29/2007 | CN101024657A Metronidazole phosphate complex with 99m Tc mark and its preparing method |
| 08/28/2007 | US7262020 Administering isotope labeled water to tissue; measurement; calibration |
| 08/28/2007 | US7261875 Dendritic poly (amino acid) carriers and methods of use |
| 08/23/2007 | WO2007095443A2 Gastrin releasing peptide compounds |
| 08/23/2007 | WO2007094718A1 Radioligands for the 5 -ht1b receptor |
| 08/23/2007 | WO2007094455A1 Positron tomography method and positron-emitting compound to be used therein |
| 08/23/2007 | WO2007093451A2 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity |
| 08/23/2007 | WO2007092981A1 Synthesis vessel, synthesis apparatus and synthesis method for preparing a pharmaceutically active substance from a suitable precursor substance |
| 08/23/2007 | WO2006067122A3 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 08/23/2007 | WO2006036269A3 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof |
| 08/23/2007 | US20070199078 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 08/23/2007 | US20070196497 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196284 Micelles associated to outer surface of liposome envelope by electrostatic interaction; active compound incorporated into the micelles linking a large amount of active compound to a single liposome carrier; bioavailability; image-enhanced contrast agents for imaging (MRI); tissue-targeted therapy |
| 08/23/2007 | US20070196278 Compositions and methods for locating an internal bleeding site |
| 08/23/2007 | US20070196277 Compositions and Methods for the Direct Therapy of Tumors |
| 08/23/2007 | US20070196276 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 08/23/2007 | US20070196275 Diagnostic Imaging Compositions, Their Methods Of Synthesis And Use |
| 08/23/2007 | US20070196274 Immunoconjugates with improved efficacy for the treatment of diseases |
| 08/23/2007 | US20070196273 Oral DTPA for radionuclide chelation |
| 08/23/2007 | US20070196272 Oral delivery of therapeutic agents using tight junction agonists |
| 08/23/2007 | US20070196271 N-(2-[4-(2-methoxyphenyl)piperazinyl]ethyl)-N-(2-pyridyl)-N-(4-18F-fluoro-methylcyclohexane)carboxamide, used for treating panic, bipolar or seizure disorders, and as a quantitative tool for measuring serotonin concentration in the brain |
| 08/23/2007 | US20070196270 Compounds As Ccri Antagonists |
| 08/23/2007 | CA2641944A1 Positron tomography method and positron-emitting compound to be used therein |
| 08/22/2007 | EP1713516B1 Method and kit for the production of particles labelled with rhenium-188 |
| 08/22/2007 | EP1562637B1 Contrast medium for representing lymph nodes |
| 08/22/2007 | CN101023164A Cancerous disease modifying antibodies |
| 08/22/2007 | CN101020698A Benzothiazole aniline compound marked with Tc-99m and its prepn process and application |
| 08/22/2007 | CN101020697A Glucose derivative complex marked with 99mTc, 188 Re or 186Re and its prepn process |
| 08/22/2007 | CN101020696A Glucose derivative complex marked with 99mTc, 188Re or 186Rc and its prepn process |
| 08/22/2007 | CN101020067A Transdermal plaster prepn for 99m TC methylene diphosphonate |
| 08/21/2007 | US7259249 Method for preparing conjugates of proteins and chelating agents |
| 08/21/2007 | CA2155947C Methods for in vivo delivery of biologics and compositions useful therefor |
| 08/16/2007 | WO2007009191A8 Method for treating cancer |
| 08/16/2007 | WO2007005612A3 An integrated approach for generating multidomain protein therapeutics |
| 08/16/2007 | WO2006055959A3 Pf4 pharmacophores and their uses |
| 08/16/2007 | WO2005012489A3 Targeting endothelium for tissue-specific delivery of agents |
| 08/16/2007 | WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 08/16/2007 | US20070190577 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 08/16/2007 | US20070189970 Contrast medium for thrombus formation |
| 08/16/2007 | US20070189967 a mixture of a benzofuran derivatives such as [2-(2-formyl-5-furanyl)-3-hydroxymethyl benzofuran], and a label selected from radioisotopes, paramagnetic particles and optical particles, used for in vivo and in vitro detection beta-amyloid in a sample of brain tissues; noninvasive medical diagnosis |
| 08/16/2007 | US20070189966 Diagnostic agents for pancreatic exocrine function |
| 08/16/2007 | US20070189965 Copper-complex isonitrile positron emission tomography (pet) imaging agent and method |
| 08/16/2007 | US20070189964 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 08/16/2007 | US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 08/16/2007 | US20070189962 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/15/2007 | EP1817062A2 Radiation dosimetry and blocking antibodies and methods and uses threfor in the treatment of cancer |
| 08/15/2007 | EP1572601B1 Solid-phase preparation of 18 f-labelled amino acids |
| 08/15/2007 | EP1499584A4 Tumor imaging compounds |
| 08/15/2007 | EP1198254B1 Carrier-drug conjugate |
| 08/15/2007 | EP0784684B1 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 08/15/2007 | CN1331980C Method for preparing water-soluble quantum point of biological functionalized sugar |
| 08/15/2007 | CN1331979C Method for preparing water-soluble quantum point of biological functionalized sugar |
| 08/15/2007 | CN1331887C Lymphoma specific chimeric monoclonal antibody against HLA-DR10 |
| 08/15/2007 | CN101015703A Antisense imaging agent and antisense oligonucleotide thereof |
| 08/14/2007 | US7256004 Detecting tumor cells expressing TAG-72 using CC49 in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present |
| 08/14/2007 | US7255850 The rates of the two arms of reverse cholesterol transport (HDL or first arm and post-HDL or second arm) are obtained by measuring the flow of unlabeled cholesterol from tissues into plasma HDL and from plasma HDL to bile acids |
| 08/09/2007 | WO2007088129A2 Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging |
| 08/09/2007 | WO2007060012A3 Use of l-phenylalanine conjugated to an emitting isotope for therapy of hormone dependent carcinoma |
| 08/09/2007 | US20070183973 Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity |
| 08/09/2007 | US20070183971 Immunoconjugates targeting syndecan-1 expressing cells and use thereof |
| 08/09/2007 | US20070183970 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 08/09/2007 | US20070183969 Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers |
| 08/09/2007 | DE102005033903B4 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them |
| 08/09/2007 | CA2635718A1 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders |
| 08/08/2007 | EP1816199A1 Mutants of thyroid stimulating hormone and methods based thereon |
| 08/08/2007 | EP1815873A1 Method and device for radiotherapy |
| 08/08/2007 | EP1815872A1 Composition for amyloid-associated disease diagnosis |
| 08/08/2007 | EP1815870A1 Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging |
| 08/08/2007 | EP1814876A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 08/08/2007 | EP1814857A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 08/08/2007 | EP1814599A2 Combination therapy using transferrin fusion proteins comprising glp-1 |
| 08/08/2007 | EP1742926B1 Macrocycle-substituted trimer halogen-benzol derivatives |
| 08/08/2007 | EP1451219B1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 08/08/2007 | CN1330635C Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method |
| 08/08/2007 | CN101011586A Diagnostic imaging contrast agents with extended blood retention |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179105 Method and means for treating solid tumors |
| 08/02/2007 | US20070178104 Methods and means for treating solid tumors |
| 08/02/2007 | US20070178045 Cyclopeptide derivatives with anti-integrin activity |
| 08/02/2007 | US20070178044 Methods for Detecting DNA Damage and Screening for Cancer Therapeutics |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 08/01/2007 | EP1813607A2 Tetraaza- or N2S2- complexants, and their use in radiodiagnostics or radiotherapy |
| 08/01/2007 | EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 08/01/2007 | EP1812082A2 Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer |
| 08/01/2007 | EP1812081A1 Method to detect dopamine receptors in the functional d2high state |
| 08/01/2007 | EP1553987B1 Method for determining gastric evacuation using a 13c-labelled test meal |
| 08/01/2007 | EP1351712B1 Targeted combination immunotherapy of cancer and infectious diseases |